Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 8:30 AM View:  | Poradosu Enrique Chief Science & Business Off | Nuvectis Pharma, Inc. (NVCT) | 19-Nov-24 | Private Purchase | 2,000 | $4.99 | $9,980.00 | < 1% 1.5M to 1.51M | |
| 18-Nov-24 8:30 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 15-Nov-24 | Private Purchase | 20,000 | $4.92 | $98,400.00 | < 1% 3.25M to 3.27M | |
| 13-Jun-24 4:21 PM View: | Oliviero James F III Director | Nuvectis Pharma, Inc. (NVCT) | 13-Jun-24 | Grant | 30,000 | -- | -- | 108% 27.83K to 57.83K | |
| 13-Jun-24 4:22 PM View: | Hoberman Kenneth Director | Nuvectis Pharma, Inc. (NVCT) | 13-Jun-24 | Grant | 30,000 | -- | -- | 41% 73.14K to 103.14K | |
| 13-Jun-24 4:22 PM View: | Kaplan Matthew L. Director | Nuvectis Pharma, Inc. (NVCT) | 13-Jun-24 | Grant | 30,000 | -- | -- | 56% 53.76K to 83.76K | |
| 15-May-24 9:16 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 14-May-24 | Market Purchase | 1,940 | $6.74 | $13,075.60 | < 1% 3.24M to 3.25M | 3% |
| 13-May-24 8:51 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 10-May-24 | Market Purchase | 2,000 | $6.40 | $12,800.00 | < 1% 3.24M to 3.24M | 8% |
| 13-May-24 8:47 AM View: | Shemesh Shay Chief Dev. & Ops. Officer | Nuvectis Pharma, Inc. (NVCT) | 10-May-24 | Market Purchase | 1,113 | $6.32 | $7,034.16 | < 1% 1.49M to 1.49M | 10% |
| 13-May-24 8:49 AM View: | Poradosu Enrique Chief Science & Business Off | Nuvectis Pharma, Inc. (NVCT) | 10-May-24 | Market Purchase | 500 | $6.29 | $3,145.00 | < 1% 1.5M to 1.5M | 10% |
| 19-Mar-24 8:00 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 18-Mar-24 | Purchase | 5,000 | $10.29 | $51,450.00 | < 1% 3.24M to 3.24M | |
| 05-Jan-24 4:30 PM View: | Shemesh Shay Chief Dev. & Ops. Officer | Nuvectis Pharma, Inc. (NVCT) | 03-Jan-24 | Grant | 130,000 | -- | -- | 10% 1.36M to 1.49M | |
| 05-Jan-24 4:31 PM View: | Poradosu Enrique Chief Science & Business Off | Nuvectis Pharma, Inc. (NVCT) | 03-Jan-24 | Grant | 130,000 | -- | -- | 9% 1.37M to 1.5M | |
| 12-Oct-23 4:05 PM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 10-Oct-23 | Purchase | 640 | $11.08 | $7,091.20 | < 1% 3.24M to 3.24M | |
| 10-Oct-23 8:30 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 09-Oct-23 | Purchase | 830 | $11.19 | $9,287.70 | < 1% 3.24M to 3.24M | |
| 10-Oct-23 8:30 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 06-Oct-23 | Purchase | 250 | $11.27 | $2,817.50 | < 1% 3.24M to 3.24M | |
| 06-Oct-23 8:37 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 05-Oct-23 | Purchase | 1,400 | $11.09 | $15,526.00 | < 1% 3.23M to 3.24M | |
| 06-Oct-23 8:37 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 04-Oct-23 | Purchase | 1,820 | $10.95 | $19,929.00 | < 1% 3.23M to 3.23M | |
| 16-Aug-23 4:05 PM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 16-Aug-23 | Purchase | 115 | $15.15 | $1,742.25 | < 1% 3.23M to 3.23M | |
| 16-Aug-23 4:05 PM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 15-Aug-23 | Purchase | 235 | $14.34 | $3,369.90 | < 1% 3.23M to 3.23M | |
| 11-Aug-23 6:07 PM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 11-Aug-23 | Purchase | 180 | $14.66 | $2,638.80 | < 1% 3.23M to 3.23M | |
| 11-Aug-23 6:07 PM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 08-Aug-23 | Purchase | 120 | $14.83 | $1,779.60 | < 1% 3.23M to 3.23M | |
| 01-Aug-23 8:00 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 31-Jul-23 | Purchase | 860 | $13.88 | $11,936.80 | < 1% 2.59M to 2.6M | |
| 31-Jul-23 8:00 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 28-Jul-23 | Purchase | 2,584 | $13.91 | $35,943.40 | < 1% 2.59M to 2.59M | |
| 28-Jul-23 8:00 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 27-Jul-23 | Purchase | 1,556 | $13.98 | $21,752.90 | < 1% 2.59M to 2.59M | |
| 27-Jul-23 6:52 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 26-Jul-23 | Purchase | 10,000 | $13.97 | $139,700.00 | < 1% 2.58M to 2.59M | |
| 24-Jul-23 4:45 PM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 21-Jul-23 | Purchase | 2,844 | $14.61 | $41,550.80 | < 1% 2.58M to 2.58M | |
| 24-Jul-23 4:45 PM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 21-Jul-23 | Purchase | 225 | $14.85 | $3,341.25 | < 1% 3.23M to 3.23M | |
| 24-Jul-23 4:45 PM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 20-Jul-23 | Purchase | 5,394 | $14.40 | $77,673.60 | < 1% 2.57M to 2.58M | |
| 24-Jul-23 4:45 PM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 20-Jul-23 | Purchase | 110 | $15.06 | $1,656.60 | < 1% 3.23M to 3.23M | |
| 20-Jul-23 6:30 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 19-Jul-23 | Purchase | 8,000 | $14.84 | $118,720.00 | < 1% 2.56M to 2.57M | |
| 20-Jul-23 6:30 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 19-Jul-23 | Purchase | 200 | $14.33 | $2,866.00 | < 1% 3.23M to 3.23M | |
| 19-Jul-23 8:06 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 18-Jul-23 | Purchase | 9,149 | $14.84 | $135,771.00 | < 1% 2.55M to 2.56M | |
| 18-Jul-23 8:34 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 14-Jul-23 | Purchase | 150 | $15.03 | $2,254.50 | < 1% 3.23M to 3.23M | |
| 13-Jul-23 8:30 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 12-Jul-23 | Purchase | 3,285 | $15.09 | $49,570.70 | < 1% 2.55M to 2.55M | |
| 12-Jul-23 8:30 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 11-Jul-23 | Purchase | 10,000 | $15.36 | $153,600.00 | < 1% 2.54M to 2.55M | |
| 18-Jul-23 8:34 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 07-Jul-23 | Purchase | 110 | $16.19 | $1,780.90 | < 1% 3.23M to 3.23M | |
| 10-Jul-23 8:00 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 07-Jul-23 | Purchase | 8,948 | $15.19 | $135,920.00 | < 1% 2.53M to 2.54M | |
| 07-Jul-23 8:04 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 06-Jul-23 | Purchase | 3,179 | $15.01 | $47,716.80 | < 1% 2.53M to 2.53M | |
| 07-Jul-23 8:03 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 06-Jul-23 | Purchase | 320 | $14.88 | $4,761.60 | < 1% 3.23M to 3.23M | |
| 06-Jul-23 7:45 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 05-Jul-23 | Purchase | 1,176 | $15.52 | $18,251.50 | < 1% 2.53M to 2.53M | |
| 27-Jun-23 8:45 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 26-Jun-23 | Purchase | 16,760 | $16.46 | $275,870.00 | < 1% 2.51M to 2.53M | |
| 27-Jun-23 8:45 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 26-Jun-23 | Purchase | 750 | $16.50 | $12,375.00 | < 1% 3.23M to 3.23M | |
| 26-Jun-23 8:45 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 23-Jun-23 | Purchase | 73,175 | $17.43 | $1,275,440.00 | 3% 2.44M to 2.51M | |
| 23-Jun-23 8:59 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 22-Jun-23 | Purchase | 6,999 | $17.73 | $124,092.00 | < 1% 2.43M to 2.44M | |
| 22-Jun-23 8:42 AM View: | Bentsur Ron Chairman & CEO Director 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 21-Jun-23 | Purchase | 500 | $17.88 | $8,940.00 | < 1% 3.23M to 3.23M | |
| 23-Jun-23 8:59 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 21-Jun-23 | Purchase | 6,091 | $17.71 | $107,872.00 | < 1% 2.42M to 2.43M | |
| 20-Jun-23 8:16 AM View: | Kaplan Matthew L. Director | Nuvectis Pharma, Inc. (NVCT) | 16-Jun-23 | Grant | 18,000 | -- | -- | 50% 35.76K to 53.76K | |
| 20-Jun-23 8:16 AM View: | Oliviero James F III Director | Nuvectis Pharma, Inc. (NVCT) | 16-Jun-23 | Grant | 18,000 | -- | -- | 183% 9.83K to 27.83K | |
| 20-Jun-23 8:15 AM View: | Hoberman Kenneth Director | Nuvectis Pharma, Inc. (NVCT) | 16-Jun-23 | Grant | 18,000 | -- | -- | 33% 55.14K to 73.14K | |
| 20-Jun-23 8:25 AM View: | Mosseri Marlio Charles 10% Owner | Nuvectis Pharma, Inc. (NVCT) | 16-Jun-23 | Purchase | 12,700 | $17.75 | $225,425.00 | < 1% 2.41M to 2.42M |
